Cite
HARVARD Citation
Hutchison, C. et al. (2019). High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial. Lancet. 6 (4), pp. e217-e228. [Online].